Spinal cord injury (SCI) represents a significant medical challenge, leading to profound and often debilitating neurological deficits that adversely affect motor, sensory, and autonomic functions. Traditional rehabilitation strategies, while essential in the management of SCI, often exhibit limited efficacy in restoring lost functions, leaving many individuals with permanent disabilities. In this context, spinal cord stimulation (SCS) emerges as a novel and promising therapeutic approach with the potential to enhance neurological recovery by promoting neural plasticity and activating residual neural pathways. This narrative review provides a comprehensive examination of SCS, elucidating its underlying mechanisms of action, technological advancements, clinical applications, and associated outcomes in patients with SCI. Both invasive (epidural) and noninvasive (transcutaneous) SCS are discussed, emphasizing their therapeutic potentials with current established evidence. This narrative review integrates findings from preclinical and clinical studies, highlighting the role of SCS in facilitating functional recovery. Furthermore, this review highlights the challenges faced in the field, including variability in patient responses, lack of standardized stimulation protocols, and the need for further research to substantiate long-term outcomes. We conclude by discussing future directions for SCS research, including the development of closed-loop systems and innovative brain-spine interfaces, which may optimize treatment delivery and enhance functional recovery in individuals with SCI.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890654 | PMC |
http://dx.doi.org/10.7759/cureus.78610 | DOI Listing |
Neurology
April 2025
Brain Health and Wellness Research Program, St. Michael's Hospital, Unity Health Toronto, Ontario, Canada.
Background And Objectives: Medical clearance for return to play (RTP) after sports-related concussion is based on clinical assessment. It is unknown whether brain physiology has entirely returned to preinjury baseline at the time of clearance. In this longitudinal study, we assessed whether concussed individuals show functional and structural MRI brain changes relative to preinjury levels that persist beyond medical clearance.
View Article and Find Full Text PDFBackground: In Germany, the incidence of traumatic spinal cord injury is approximately 16 per million inhabitants per year. This article aims to present evidence-based diagnostic and therapeutic measures for the first 14 days after injury to minimize neural damage, prevent complications, and preserve functioning as much as possible.
Methods: After the formulation of key questions, systematic literature searches were carried out on multiple topics.
Sci Robot
March 2025
NeuroX Institute and Brain Mind Institute, School of Life Sciences, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.
Rehabilitation robotics aims to promote activity-dependent reorganization of the nervous system. However, people with paralysis cannot generate sufficient activity during robot-assisted rehabilitation and, consequently, do not benefit from these therapies. Here, we developed an implantable spinal cord neuroprosthesis operating in a closed loop to promote robust activity during walking and cycling assisted by robotic devices.
View Article and Find Full Text PDFElife
March 2025
Department of Complex Systems, Institute of Computer Science of the Czech Academy of Sciences, Prague, Czech Republic.
Longitudinal neuroimaging studies offer valuable insight into brain development, ageing, and disease progression over time. However, prevailing analytical approaches rooted in our understanding of population variation are primarily tailored for cross-sectional studies. To fully leverage the potential of longitudinal neuroimaging, we need methodologies that account for the complex interplay between population variation and individual dynamics.
View Article and Find Full Text PDFCell Mol Neurobiol
March 2025
Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Institute of Neuroscience and Third Affiliated Hospital of Zhengzhou University, Kangfu Qian Street 7, Zhengzhou, 450052, China.
Neuroinflammation is a key factor in the development of preterm white matter injury (PWMI), leading to glial cell dysfunction, arrest of oligodendrocyte maturation, and long-term neurological damage. As a potential therapeutic strategy, mesenchymal stem cells (MSCs) exhibit significant immunomodulatory and regenerative potential. Recent studies suggest that the primary mechanism of MSC action is their paracrine effects, particularly mediated by extracellular vesicles, with MSC-derived exosomes (MSC-Exos) being the key mediators.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!